Drug Topics

NOVEMBER 15, 2023

Compounding parenteral nutrition solutions is a complex process with a high risk for error, which can lead to serious adverse outcomes.

Compounding 329

Compounding 329

PharmaVoice

NOVEMBER 15, 2023

Talus Bio, which developed a platform to map transcription factors, has a lead cancer candidate in the works and consults with other industry players in the complicated biology.

195

195

Drug Topics

NOVEMBER 15, 2023

Presenters at a NCPA 2023 session highlighted the importance of overcoming hesitations to implement new clinical services and taking an employee-centric approach in doing so.

281

281

Pharmacy Times

NOVEMBER 15, 2023

The drug may be a risk factor for dementia-related illnesses.

181

181

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

NOVEMBER 15, 2023

A study found that around 75% of children who had reported experiencing pollen-AR by the ages of 4 or 8 continued to have persisted in their condition until they reached 24 years of age.

247

247

Pharmacy Times

NOVEMBER 15, 2023

The business model took time to catch up to pharmacy’s potential, and community-based patient care leads the way

Community Pharmacies 164

Community Pharmacies Patient Care 164

Pharmacy Times

NOVEMBER 15, 2023

Taurolidine and heparin (Defencath; CorMedix) is indicated to reduce catheter-related bloodstream infections for adults with kidney failure who are receiving chronic hemodialysis via central venous catheter

FDA 156

FDA 156

STAT

NOVEMBER 15, 2023

Step inside Natasha Sheybani’s office at the University of Virginia, where she runs a bioengineering lab, and you’ll find a kaleidoscopic sea of sticky notes. She uses purple for ideas sparked by meetings, orange for future grant proposals. But she’s most excited about the yellow stickies, which Sheybani saves for moonshots: projects that are high-risk and high-reward.

145

145

Pharmacy Times

NOVEMBER 15, 2023

The approval will benefit patients who have difficulty swallowing, dysphagia, or high taste sensitivities and struggle to adhere to the original antibiotic.

FDA 145

FDA 145

Fierce Healthcare

NOVEMBER 15, 2023

Primary care player Forward unveiled this week what it has been quietly working on the past two years—self-serve CarePods that use artificial intelligence to screen and diagnose health conditions.< | Primary care player Forward unveiled this week what it has been quietly working on the past two years—self-serve CarePods that use artificial intelligence to screen and diagnose health conditions.

144

144

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

NOVEMBER 15, 2023

Session speaker Powell-Wiley explains how screening for SDOH in patients as cardiovascular-kidney-metabolic syndrome stages progress can help better understand their individual social needs.

145

145

Fierce Healthcare

NOVEMBER 15, 2023

UnitedHealthcare is facing a potential class action lawsuit following allegations that it used an algorithm to deny claims for post-acute care services in Medicare Advantage. | UnitedHealthcare is facing a potential class action lawsuit following allegations that it used an algorithm to deny claims for post-acute care services in Medicare Advantage.

142

142

STAT

NOVEMBER 15, 2023

WASHINGTON — House lawmakers late Tuesday voted to attach a U.S. ban on controversial infectious disease research to legislation that could ultimately fund federal health agencies like the National Institutes of Health. The bill would bar any federal agencies from funding so-called gain-of-function research, which involves altering a pathogen to study its spread, potentially making it more transmissible or severe in the process.

140

140

Pharmacy Times

NOVEMBER 15, 2023

Researchers provided recommendations based on the current status of COVID-19 infection and role of therapies.

139

139

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Healthcare

NOVEMBER 15, 2023

The House Committee on Energy and Commerce health subcommittee pushed forward 21 proposals on Tuesday, some of which will restrict the power of pharmacy benefit managers (PBMs). | PBMs were a source of bipartisan agreement during a House hearing on Tuesday, while Republicans and Democrats clashed over durable medical equipment legislation.

139

139

Pharmacy Times

NOVEMBER 15, 2023

In this episode, you'll hear a conversation with Ron Lanton, partner at Lanton Law, who gets us up to speed on all of the legal cases surrounding this issue thus far.

139

139

STAT

NOVEMBER 15, 2023

One day in early 2020, just weeks before Philadelphia entered lockdown, Thomas Jefferson University’s public safety lead Joseph Byham abandoned a brisk walk to respond to an urgent incident. A clinician at one of Jefferson’s Center City hospitals had pressed a badge-worn button summoning security immediately: a traumatic brain injury patient was attempting to flee, and they feared it would escalate into violence.

Hospitals 137

Hospitals 137

Fierce Pharma

NOVEMBER 15, 2023

In response to an onslaught from Eli Lilly, Novo Nordisk is escalating the obesity market battle with a new head-to-head trial against its archrival. | In response to an onslaught from Eli Lilly, Novo Nordisk is escalating the obesity market battle with a new head-to-head trial against its archrival.

136

136

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Pharmacy Times

NOVEMBER 15, 2023

Investigators believe that the activation of mast cells drives inflammation and contributes to plaque buildup, causing heart attacks and other damage to the heart.

132

132

PharmaVoice

NOVEMBER 15, 2023

23andMe co-founder and CEO Anne Wojcicki discusses ways the industry could integrate genomics into healthcare.

130

130

STAT

NOVEMBER 15, 2023

Convenience is rapidly becoming a guiding principle for hospital system strategy and competition. As patients demand a more convenient, integrated care experience, and new partnerships/acquisitions (for instance, CVS Health and Oak Street Health, or Amazon and One Medical) redefine what the consumer health care journey looks like, the industry will continue to see a collision between virtual, at-home, and in-person care.

Hospitals 129

Hospitals 129

Fierce Healthcare

NOVEMBER 15, 2023

Postmeds, doing business as Truepill, confirmed that hackers accessed the personal data of more than 2.3 million patients. | Postmeds, doing business as Truepill, confirmed that hackers accessed the personal data of more than 2.3 million patients.

125

125

STAT

NOVEMBER 15, 2023

WASHINGTON — Panels in both the House and Senate have now passed restrictions to drug middlemen business practices, increasing the chances of those measures being included in future government spending bills. The bipartisan reforms to pharmacy benefit managers were among 21 bills that the House Energy & Commerce health subcommittee passed today.

Insurance 127

Insurance 127

pharmaphorum

NOVEMBER 15, 2023

The evolving landscape of medicinal cannabis and its synergy with pharmaceutical giants Nicole.

124

124

STAT

NOVEMBER 15, 2023

LONDON — Clinical trials have shown that lifestyle programs — which include diet, exercise, and behavioral coaching — can help people in danger of developing type 2 diabetes from tipping into a diagnosis of the condition. But there’s been a nagging question of whether such intensive regimens work in the real world. A study published Wednesday backs up the idea that they can.

127

127

Pharmacy Times

NOVEMBER 15, 2023

The genes that predispose a person to sleep problems can impact that person across their entire lifetime, so interventions targeted toward a younger audience could be beneficial.

123

123

STAT

NOVEMBER 15, 2023

The patents on medicines and devices approved by the U.S. Food and Drug Administration were more frequently invalidated due to information misrepresented or withheld from patent examiners than any other industry sector, according to a new analysis. Between 2004 and 2021, a U.S. appeals court that handles patent litigation found 36 cases in which companies committed what is called inequitable conduct — failing to provide accurate or complete information to the U.S.

FDA 126

FDA 126

Fierce Healthcare

NOVEMBER 15, 2023

Summer Health launched a year ago as a text-based service for parents to get answers to urgent needs from pediatricians. | There is a growing shortage of pediatric clinicians. To meet the demand for primary care services, Summer Health rolled out a new on-demand text message service for parents to connect with pediatricians, sleep coaches and lactation experts.

122

122

STAT

NOVEMBER 15, 2023

WASHINGTON — There’s about to be a new acronym in town. The Food and Drug Administration is in the final stages of cementing sweeping changes to the Office of Regulatory Affairs, which oversees inspections and compliance for all its regulated products, according to three people familiar with the planning. That overhaul includes a new name: Meet the Office of Inspections and Investigations.

FDA 126

FDA 126

PharmExec

NOVEMBER 15, 2023

Defencath is indicated for the prevention and treatment of catheter-related bloodstream infections in adults with kidney failure administered chronic hemodialysis via a central venous catheter.

FDA 119

FDA 119

STAT

NOVEMBER 15, 2023

For the many high-achieving perfectionists who enter medical school each year, the stakes of their success have never been higher. Becoming a doctor means lives will be in their hands — and failing to make it through med school means they’ll be stuck with an unthinkable amount of debt without a viable way to pay for it. It’s no wonder that medical students suffer greatly from burnout and mental health struggles.

Insurance 120

Insurance Medical Schools 120

Fierce Pharma

NOVEMBER 15, 2023

How popular have Novo Nordisk’s semaglutide drugs become for weight loss in Europe? | How popular have Novo Nordisk’s semaglutide drugs become for weight loss in Europe? The craze is such that Germany’s drug regulator is considering banning the export of Ozempic, according to a report in Der Spiegel magazine.

119

119

STAT

NOVEMBER 15, 2023

WASHINGTON — The Food and Drug Administration’s top cancer drug regulator doesn’t always ask for permission before taking on big initiatives. Richard Pazdur, director of the FDA Oncology Center of Excellence, hates bureaucracy. It stifles his ideas for getting treatments to cancer patients faster — of which there are many.

FDA 116

FDA 116